Cost paramount when choosing metastatic breast cancer treatmentSeptember 30, 2022Breast CancerOncology
Despite benefits, extended-interval pembro uptake remains lowSeptember 28, 2022Lung CancerColon and RectalHead & Neck/Thyroid CancersMelanomaGenitourinary Cancer
Genetic tests create treatment opportunities and confusion for breast cancer patientsSeptember 22, 2022Breast Cancer
Atezolizumab doubles survival of NSCLC patients with poor performance statusSeptember 19, 2022Lung CancerOncology
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022OncologyMixed TopicsBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLung CancerMelanoma
Biden’s Cancer Moonshot turns its focus to early-detection blood testsSeptember 19, 2022OncologyMixed Topics
